Global Cord Blood Corporation (DE:6CB)
BERLIN:6CB

Global Cord Blood (DE:6CB) Stock Price & Analysis

0 Followers

6CB Stock Chart & Stats

Day’s Range€0 - €0
52-Week Range€2.02 - €4.46
Previous Close€3.1
Volume0.00
Average Volume (3M)N/A
Market CapN/A
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)N/A
Beta-0.66
Next EarningsFeb 27, 2023
EPS EstimateN/A
Dividend YieldN/A
1Y Price TargetN/A
EPS (TTM)N/A
Shares Outstanding133,914,711
R-SquaredN/A
Standard DeviationN/A
10 Day Avg. Volume0
30 Day Avg. VolumeN/A
Price to Book (P/B)0.53
Price to Sales (P/S)9.75
Price to Cash Flow (P/CF)4.10
P/FCF Ratio4.30
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Price Target UpsideN/A
Rating ConsensusN/A
AlphaN/A
Number of Analyst Covering0


6CB FAQ

What was Global Cord Blood’s price range in the past 12 months?
Global Cord Blood lowest stock price was €2.02 and its highest was €4.46 in the past 12 months.
    What is Global Cord Blood’s market cap?
    Currently, no data Available
    When is Global Cord Blood’s upcoming earnings report date?
    Global Cord Blood’s upcoming earnings report date is Feb 27, 2023 which is in 31 days.
      How were Global Cord Blood’s earnings last quarter?
      Currently, no data Available
      Is Global Cord Blood overvalued?
      According to Wall Street analysts Global Cord Blood’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
        Does Global Cord Blood pay dividends?
        Global Cord Blood pays a Notavailable dividend of €0.07 which represents an annual dividend yield of N/A. See more information on Global Cord Blood dividends here
          What is Global Cord Blood’s EPS estimate?
          Global Cord Blood’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Global Cord Blood have?
          Currently, no data Available
          What happened to Global Cord Blood’s price movement after its last earnings report?
          Currently, no data Available
          Which hedge fund is a major shareholder of Global Cord Blood?
          Among the largest hedge funds holding Global Cord Blood’s share is Caxton Associates LP. It holds Global Cord Blood’s shares valued at N/A.

            ---

            Global Cord Blood Stock Smart Score

            The Global Cord Blood Holdings stock analysis is based on the TipRanks Smart Score which is derived from 6 unique data sets including Analyst recommendations, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
            Learn more about TipRanks Smart Score

            Company Description

            Global Cord Blood Corporation

            Global Cord Blood operates as a holding company, which engages in the provision of cord blood banking services. It provides cord blood processing and storage service. The company also offers cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services. It preserves cord blood units donated by the public and provides matching services on such donated units and deliver matching units to patients in need of transplants. Global Cord Blood was founded on January 17, 2008 and is headquartered in Hong Kong.

            ---

            Forecast EPS vs Actual EPS

            Currently, no data available
            Please return soon. This page is being updated.

            Similar Stocks
            Company
            Price & Change
            Follow
            Global Cord Blood
            Medical Care Technologies
            Concord Medical Services
            China Xd Plastics Company
            China Pharma Holdings

            Popular Stocks

            ---
            What's Included in PREMIUM?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis